Amanda Enyeart

2 months ago | jdsupra.com | Grayson Dimick |Amanda Enyeart |Gregory Mitchell

KEY UPDATEThe recently released New York State Executive Budget for Fiscal Year 2026 contains proposed revisions to a recently enacted law impacting how healthcare providers obtain patients’ consent to payment. NY Public Health Law (PHL) § 18-c currently requires that patients provide consent for payment separate from consent to receive healthcare services. That consent to payment cannot be given before the provider discusses treatment costs with the patient and the patient receives services.

Dec 16, 2024 | jdsupra.com | Amanda Enyeart

Trending in Telehealth highlights state legislative and regulatory developments that impact the healthcare providers, telehealth and digital health companies, pharmacists, and technology companies that deliver and facilitate the delivery of virtual care. Trending in the past two weeks: Behavioral and mental telehealth Coverage and payment parityA CLOSER LOOKProposed Legislation & Rulemaking: In Illinois, HB 4475 gained another co-sponsor.

Nov 25, 2024 | mondaq.com | Tony Maida |Emily Cook |Monica Wallace |Amanda Enyeart

This issue of McDermott's Healthcare Regulatory Check-Up highlights regulatory activity for October 2024. We discuss several enforcement actions pertaining to healthcare fraud, including alleged violations under the False Claims Act (FCA) and the federal Anti-Kickback Statute (AKS). We also review other regulatory updates in the healthcare field, including notable updates from the Centers for Medicare & Medicaid Services (CMS). READ FULL REPORT.

Nov 21, 2024 | jdsupra.com | Emily Cook |Amanda Enyeart |MaryKathryn Hurd

This issue of McDermott’s Healthcare Regulatory Check-Up highlights regulatory activity for October 2024. We discuss several enforcement actions pertaining to healthcare fraud, including alleged violations under the False Claims Act (FCA) and the federal Anti-Kickback Statute (AKS). We also review other regulatory updates in the healthcare field, including notable updates from the Centers for Medicare & Medicaid Services (CMS). Please see full publication below for more information.

Nov 19, 2024 | mondaq.com | Lisa S. Mazur |Dale Van Demark |Amanda Enyeart |Marshall Jackson

The US Drug Enforcement Administration (DEA) further extended flexibilities that allow providers to prescribe controlled substances via telemedicine without first performing an in-person visit. The flexibilities were initially provided during the COVID-19 public health emergency (PHE) and were scheduled to expire on December 31, 2024. This extension extends the flexibilities through December 31, 2025.